Showing results (71-80 of 3,994) with videos related to
Sort By:
Pageof 400
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in ratsW Linz, B A Schölkens, D GantenThe American Journal of Cardiology|April 24, 1987
Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implicationsT Unger, D Ganten, R E LangHypertension Research : Official Journal of the Japanese Society of Hypertension|December 1, 1996
Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic ratsM Wegner, D Ganten, J P StaschThe American Journal of Physiology|September 1, 1981
Isoproterenol-induced thirst: renal and extrarenal mechanismsR Rettig, D Ganten, A K JohnsonJournal of Cardiovascular Pharmacology|January 1, 1986
Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitorsT Unger, D Ganten, R E LangCirculation|November 1, 1995
Genetic linkage of the ACE gene to plasma angiotensin-converting enzyme activity but not to blood pressure. A quantitative trait locus confers identical complex phenotypes in human and rat hypertensionR Kreutz, N Hübner, D Ganten, et al.Neuroscience Letters|July 17, 2009
Immunohistochemical evidence for the existence of angiotensin II-containing nerve terminals in the brain and spinal cord in the ratK Fuxe, D Ganten, T Hökfelt, et al.The American Journal of Physiology|May 1, 1994
Renal function in hypertensive rats transgenic for mouse renin geneJ E Springate, L G Feld, D GantenBrain Research|November 12, 1984
Angiotensin II immunoreactivity in the neural afferents and efferents of the subfornical organ of the ratR W Lind, L W Swanson, D GantenJournal of Neuroendocrinology|February 13, 2009
An Ultrastructural Analysis of the Distribution of Angiotensin II in the Rat BrainB J Oldfield, D Ganten, M J McKinleyPageof 400